nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—type 2 diabetes mellitus—atherosclerosis	0.358	1	CtDrD
Glyburide—ABCA1—atherosclerosis	0.19	0.881	CbGaD
Glyburide—ALB—atherosclerosis	0.0256	0.118	CbGaD
Glyburide—SLCO2B1—Niacin—atherosclerosis	0.024	0.0802	CbGbCtD
Glyburide—SLCO2B1—Rosuvastatin—atherosclerosis	0.0204	0.0682	CbGbCtD
Glyburide—ABCC3—Ezetimibe—atherosclerosis	0.0204	0.0682	CbGbCtD
Glyburide—SLCO2B1—Pravastatin—atherosclerosis	0.0186	0.062	CbGbCtD
Glyburide—ABCB11—Rosuvastatin—atherosclerosis	0.0177	0.0589	CbGbCtD
Glyburide—ABCB11—Pravastatin—atherosclerosis	0.0161	0.0536	CbGbCtD
Glyburide—SLC22A7—Pravastatin—atherosclerosis	0.0145	0.0485	CbGbCtD
Glyburide—ABCC1—Rosuvastatin—atherosclerosis	0.0126	0.0418	CbGbCtD
Glyburide—SLCO1A2—Rosuvastatin—atherosclerosis	0.0112	0.0374	CbGbCtD
Glyburide—SLCO1A2—Simvastatin—atherosclerosis	0.0104	0.0347	CbGbCtD
Glyburide—SLCO1A2—Pravastatin—atherosclerosis	0.0102	0.034	CbGbCtD
Glyburide—SLCO1A2—Lovastatin—atherosclerosis	0.0102	0.034	CbGbCtD
Glyburide—ABCC2—Ezetimibe—atherosclerosis	0.00929	0.031	CbGbCtD
Glyburide—ABCC2—Simvastatin—atherosclerosis	0.00864	0.0288	CbGbCtD
Glyburide—ABCC2—Pravastatin—atherosclerosis	0.00845	0.0282	CbGbCtD
Glyburide—ABCC2—Lovastatin—atherosclerosis	0.00845	0.0282	CbGbCtD
Glyburide—ABCG2—Ezetimibe—atherosclerosis	0.0084	0.028	CbGbCtD
Glyburide—ABCG2—Rosuvastatin—atherosclerosis	0.0084	0.028	CbGbCtD
Glyburide—ABCG2—Pravastatin—atherosclerosis	0.00764	0.0255	CbGbCtD
Glyburide—SLC22A6—Pravastatin—atherosclerosis	0.00619	0.0206	CbGbCtD
Glyburide—ALB—Rosuvastatin—atherosclerosis	0.00579	0.0193	CbGbCtD
Glyburide—CYP2C19—Rosuvastatin—atherosclerosis	0.00375	0.0125	CbGbCtD
Glyburide—CYP2C19—Simvastatin—atherosclerosis	0.00349	0.0116	CbGbCtD
Glyburide—CYP2C19—Lovastatin—atherosclerosis	0.00342	0.0114	CbGbCtD
Glyburide—CYP2C9—Rosuvastatin—atherosclerosis	0.00312	0.0104	CbGbCtD
Glyburide—ABCB1—Ezetimibe—atherosclerosis	0.00303	0.0101	CbGbCtD
Glyburide—CYP2C9—Simvastatin—atherosclerosis	0.0029	0.00967	CbGbCtD
Glyburide—CYP2C9—Pravastatin—atherosclerosis	0.00284	0.00947	CbGbCtD
Glyburide—CYP2C9—Lovastatin—atherosclerosis	0.00284	0.00947	CbGbCtD
Glyburide—ABCB1—Simvastatin—atherosclerosis	0.00282	0.00939	CbGbCtD
Glyburide—ABCB1—Pravastatin—atherosclerosis	0.00276	0.00919	CbGbCtD
Glyburide—ABCB1—Lovastatin—atherosclerosis	0.00276	0.00919	CbGbCtD
Glyburide—KCNJ1—appendage—atherosclerosis	0.0019	0.125	CbGeAlD
Glyburide—CYP3A4—Ezetimibe—atherosclerosis	0.00181	0.00605	CbGbCtD
Glyburide—CYP3A4—Rosuvastatin—atherosclerosis	0.00181	0.00605	CbGbCtD
Glyburide—CYP3A4—Simvastatin—atherosclerosis	0.00169	0.00562	CbGbCtD
Glyburide—CYP3A4—Lovastatin—atherosclerosis	0.00165	0.0055	CbGbCtD
Glyburide—CYP3A4—Pravastatin—atherosclerosis	0.00165	0.0055	CbGbCtD
Glyburide—ABCC8—penis—atherosclerosis	0.00164	0.108	CbGeAlD
Glyburide—ABCA1—artery—atherosclerosis	0.00129	0.085	CbGeAlD
Glyburide—Nephropathy—Rosuvastatin—atherosclerosis	0.00109	0.0241	CcSEcCtD
Glyburide—ABCA1—blood vessel—atherosclerosis	0.00101	0.0662	CbGeAlD
Glyburide—KCNJ5—cardiovascular system—atherosclerosis	0.000874	0.0575	CbGeAlD
Glyburide—ABCC9—cardiovascular system—atherosclerosis	0.000662	0.0436	CbGeAlD
Glyburide—ABCC9—adipose tissue—atherosclerosis	0.000584	0.0384	CbGeAlD
Glyburide—CPT1A—connective tissue—atherosclerosis	0.000554	0.0364	CbGeAlD
Glyburide—Heartburn—Niacin—atherosclerosis	0.000547	0.0121	CcSEcCtD
Glyburide—Heartburn—Pravastatin—atherosclerosis	0.000539	0.0119	CcSEcCtD
Glyburide—ABCA1—connective tissue—atherosclerosis	0.000516	0.034	CbGeAlD
Glyburide—Jaundice cholestatic—Lovastatin—atherosclerosis	0.000499	0.0111	CcSEcCtD
Glyburide—Cholestasis—Niacin—atherosclerosis	0.000496	0.011	CcSEcCtD
Glyburide—CPT1A—cardiovascular system—atherosclerosis	0.000482	0.0317	CbGeAlD
Glyburide—Jaundice cholestatic—Simvastatin—atherosclerosis	0.000467	0.0103	CcSEcCtD
Glyburide—Vasculitis—Lovastatin—atherosclerosis	0.000449	0.00996	CcSEcCtD
Glyburide—ABCA1—cardiovascular system—atherosclerosis	0.000449	0.0295	CbGeAlD
Glyburide—Vasculitis—Ezetimibe—atherosclerosis	0.000441	0.00977	CcSEcCtD
Glyburide—Jaundice cholestatic—Niacin—atherosclerosis	0.000428	0.0095	CcSEcCtD
Glyburide—CPT1A—adipose tissue—atherosclerosis	0.000425	0.028	CbGeAlD
Glyburide—Jaundice cholestatic—Pravastatin—atherosclerosis	0.000422	0.00936	CcSEcCtD
Glyburide—Vasculitis—Simvastatin—atherosclerosis	0.00042	0.00932	CcSEcCtD
Glyburide—Hepatic failure—Rosuvastatin—atherosclerosis	0.000418	0.00927	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Niacin—atherosclerosis	0.000414	0.00918	CcSEcCtD
Glyburide—ABCC9—liver—atherosclerosis	0.000409	0.027	CbGeAlD
Glyburide—Renal failure acute—Rosuvastatin—atherosclerosis	0.000407	0.00902	CcSEcCtD
Glyburide—ABCA1—adipose tissue—atherosclerosis	0.000396	0.0261	CbGeAlD
Glyburide—Vasculitis—Pravastatin—atherosclerosis	0.00038	0.00842	CcSEcCtD
Glyburide—Bezafibrate—HMGCR—atherosclerosis	0.000378	0.24	CrCbGaD
Glyburide—Bezafibrate—PPARA—atherosclerosis	0.000372	0.236	CrCbGaD
Glyburide—Hepatic function abnormal—Lovastatin—atherosclerosis	0.000364	0.00808	CcSEcCtD
Glyburide—Vascular purpura—Lovastatin—atherosclerosis	0.000356	0.00789	CcSEcCtD
Glyburide—Hepatic failure—Lovastatin—atherosclerosis	0.000354	0.00785	CcSEcCtD
Glyburide—Haemolytic anaemia—Lovastatin—atherosclerosis	0.000352	0.00782	CcSEcCtD
Glyburide—Hepatic failure—Ezetimibe—atherosclerosis	0.000347	0.0077	CcSEcCtD
Glyburide—Hepatic function abnormal—Simvastatin—atherosclerosis	0.000341	0.00755	CcSEcCtD
Glyburide—Vascular purpura—Simvastatin—atherosclerosis	0.000333	0.00738	CcSEcCtD
Glyburide—Hepatic failure—Simvastatin—atherosclerosis	0.000331	0.00735	CcSEcCtD
Glyburide—Purpura—Lovastatin—atherosclerosis	0.00033	0.00732	CcSEcCtD
Glyburide—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00033	0.00731	CcSEcCtD
Glyburide—Arthritis—Lovastatin—atherosclerosis	0.000327	0.00726	CcSEcCtD
Glyburide—Arthritis—Ezetimibe—atherosclerosis	0.000321	0.00712	CcSEcCtD
Glyburide—Pancreatitis—Rosuvastatin—atherosclerosis	0.000318	0.00706	CcSEcCtD
Glyburide—Gliclazide—VEGFA—atherosclerosis	0.000317	0.202	CrCbGaD
Glyburide—Hepatic function abnormal—Niacin—atherosclerosis	0.000313	0.00694	CcSEcCtD
Glyburide—Purpura—Simvastatin—atherosclerosis	0.000309	0.00685	CcSEcCtD
Glyburide—Hepatic function abnormal—Pravastatin—atherosclerosis	0.000308	0.00683	CcSEcCtD
Glyburide—Arthritis—Simvastatin—atherosclerosis	0.000306	0.00679	CcSEcCtD
Glyburide—Vascular purpura—Pravastatin—atherosclerosis	0.000301	0.00667	CcSEcCtD
Glyburide—Deafness—Pravastatin—atherosclerosis	0.000301	0.00667	CcSEcCtD
Glyburide—Hepatic failure—Pravastatin—atherosclerosis	0.000299	0.00664	CcSEcCtD
Glyburide—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000298	0.00661	CcSEcCtD
Glyburide—CPT1A—liver—atherosclerosis	0.000298	0.0196	CbGeAlD
Glyburide—Renal failure acute—Pravastatin—atherosclerosis	0.000291	0.00646	CcSEcCtD
Glyburide—KCNJ11—cardiovascular system—atherosclerosis	0.000286	0.0188	CbGeAlD
Glyburide—Dermatitis bullous—Niacin—atherosclerosis	0.000286	0.00634	CcSEcCtD
Glyburide—Jaundice—Rosuvastatin—atherosclerosis	0.000282	0.00626	CcSEcCtD
Glyburide—Arthritis—Niacin—atherosclerosis	0.000281	0.00624	CcSEcCtD
Glyburide—Purpura—Pravastatin—atherosclerosis	0.000279	0.00619	CcSEcCtD
Glyburide—ABCA1—liver—atherosclerosis	0.000278	0.0183	CbGeAlD
Glyburide—Arthritis—Pravastatin—atherosclerosis	0.000277	0.00614	CcSEcCtD
Glyburide—Eosinophilia—Lovastatin—atherosclerosis	0.000272	0.00604	CcSEcCtD
Glyburide—Pancreatitis—Lovastatin—atherosclerosis	0.00027	0.00598	CcSEcCtD
Glyburide—Diplopia—Pravastatin—atherosclerosis	0.000269	0.00597	CcSEcCtD
Glyburide—Eosinophilia—Ezetimibe—atherosclerosis	0.000267	0.00592	CcSEcCtD
Glyburide—Pancreatitis—Ezetimibe—atherosclerosis	0.000264	0.00587	CcSEcCtD
Glyburide—ABCC8—cardiovascular system—atherosclerosis	0.000264	0.0174	CbGeAlD
Glyburide—CFTR—liver—atherosclerosis	0.000262	0.0173	CbGeAlD
Glyburide—Hepatitis—Rosuvastatin—atherosclerosis	0.00026	0.00576	CcSEcCtD
Glyburide—Eosinophilia—Simvastatin—atherosclerosis	0.000255	0.00565	CcSEcCtD
Glyburide—Pancreatitis—Simvastatin—atherosclerosis	0.000252	0.00559	CcSEcCtD
Glyburide—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000251	0.00557	CcSEcCtD
Glyburide—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000246	0.00546	CcSEcCtD
Glyburide—Glipizide—PPARG—atherosclerosis	0.000244	0.155	CrCbGaD
Glyburide—Abdominal distension—Niacin—atherosclerosis	0.000238	0.00527	CcSEcCtD
Glyburide—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000235	0.00521	CcSEcCtD
Glyburide—Jaundice—Ezetimibe—atherosclerosis	0.000234	0.0052	CcSEcCtD
Glyburide—Abdominal distension—Pravastatin—atherosclerosis	0.000234	0.00519	CcSEcCtD
Glyburide—Eosinophilia—Pravastatin—atherosclerosis	0.00023	0.00511	CcSEcCtD
Glyburide—Pancreatitis—Pravastatin—atherosclerosis	0.000228	0.00506	CcSEcCtD
Glyburide—Sweating increased—Pravastatin—atherosclerosis	0.000227	0.00502	CcSEcCtD
Glyburide—Jaundice—Simvastatin—atherosclerosis	0.000224	0.00496	CcSEcCtD
Glyburide—Hepatitis—Lovastatin—atherosclerosis	0.00022	0.00488	CcSEcCtD
Glyburide—Hepatitis—Ezetimibe—atherosclerosis	0.000216	0.00479	CcSEcCtD
Glyburide—ABCB11—liver—atherosclerosis	0.000215	0.0142	CbGeAlD
Glyburide—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000212	0.00471	CcSEcCtD
Glyburide—Angioedema—Rosuvastatin—atherosclerosis	0.000207	0.00458	CcSEcCtD
Glyburide—Hepatitis—Simvastatin—atherosclerosis	0.000206	0.00457	CcSEcCtD
Glyburide—Jaundice—Niacin—atherosclerosis	0.000205	0.00455	CcSEcCtD
Glyburide—Jaundice—Pravastatin—atherosclerosis	0.000202	0.00448	CcSEcCtD
Glyburide—ABCC3—adipose tissue—atherosclerosis	0.000195	0.0128	CbGeAlD
Glyburide—Alopecia—Lovastatin—atherosclerosis	0.000195	0.00431	CcSEcCtD
Glyburide—SLC22A7—liver—atherosclerosis	0.000194	0.0128	CbGeAlD
Glyburide—Arthralgia—Rosuvastatin—atherosclerosis	0.000193	0.00427	CcSEcCtD
Glyburide—Myalgia—Rosuvastatin—atherosclerosis	0.000193	0.00427	CcSEcCtD
Glyburide—Alopecia—Ezetimibe—atherosclerosis	0.000191	0.00423	CcSEcCtD
Glyburide—Hepatitis—Niacin—atherosclerosis	0.000189	0.00419	CcSEcCtD
Glyburide—Erythema—Ezetimibe—atherosclerosis	0.000188	0.00417	CcSEcCtD
Glyburide—Malnutrition—Ezetimibe—atherosclerosis	0.000188	0.00417	CcSEcCtD
Glyburide—Hepatitis—Pravastatin—atherosclerosis	0.000186	0.00413	CcSEcCtD
Glyburide—Confusional state—Rosuvastatin—atherosclerosis	0.000186	0.00413	CcSEcCtD
Glyburide—Visual impairment—Niacin—atherosclerosis	0.000182	0.00404	CcSEcCtD
Glyburide—Alopecia—Simvastatin—atherosclerosis	0.000182	0.00404	CcSEcCtD
Glyburide—SLCO2B1—adipose tissue—atherosclerosis	0.000182	0.012	CbGeAlD
Glyburide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000181	0.00401	CcSEcCtD
Glyburide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000181	0.00401	CcSEcCtD
Glyburide—Vision blurred—Lovastatin—atherosclerosis	0.000181	0.00401	CcSEcCtD
Glyburide—Tremor—Lovastatin—atherosclerosis	0.00018	0.00398	CcSEcCtD
Glyburide—Visual impairment—Pravastatin—atherosclerosis	0.000179	0.00398	CcSEcCtD
Glyburide—Erythema—Simvastatin—atherosclerosis	0.000179	0.00398	CcSEcCtD
Glyburide—Bezafibrate—PPARG—atherosclerosis	0.000178	0.113	CrCbGaD
Glyburide—Eye disorder—Niacin—atherosclerosis	0.000177	0.00392	CcSEcCtD
Glyburide—Angioedema—Lovastatin—atherosclerosis	0.000175	0.00388	CcSEcCtD
Glyburide—Anaemia—Ezetimibe—atherosclerosis	0.000174	0.00385	CcSEcCtD
Glyburide—Angioedema—Ezetimibe—atherosclerosis	0.000172	0.00381	CcSEcCtD
Glyburide—Leukopenia—Lovastatin—atherosclerosis	0.000172	0.0038	CcSEcCtD
Glyburide—Vision blurred—Simvastatin—atherosclerosis	0.000169	0.00375	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000168	0.00373	CcSEcCtD
Glyburide—Tremor—Simvastatin—atherosclerosis	0.000168	0.00372	CcSEcCtD
Glyburide—Alopecia—Niacin—atherosclerosis	0.000167	0.00371	CcSEcCtD
Glyburide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000166	0.00368	CcSEcCtD
Glyburide—Anaemia—Simvastatin—atherosclerosis	0.000166	0.00367	CcSEcCtD
Glyburide—Malnutrition—Niacin—atherosclerosis	0.000165	0.00365	CcSEcCtD
Glyburide—Erythema—Niacin—atherosclerosis	0.000165	0.00365	CcSEcCtD
Glyburide—Alopecia—Pravastatin—atherosclerosis	0.000165	0.00365	CcSEcCtD
Glyburide—Angioedema—Simvastatin—atherosclerosis	0.000164	0.00363	CcSEcCtD
Glyburide—Arthralgia—Lovastatin—atherosclerosis	0.000163	0.00362	CcSEcCtD
Glyburide—Myalgia—Lovastatin—atherosclerosis	0.000163	0.00362	CcSEcCtD
Glyburide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000162	0.0036	CcSEcCtD
Glyburide—Leukopenia—Simvastatin—atherosclerosis	0.00016	0.00356	CcSEcCtD
Glyburide—Arthralgia—Ezetimibe—atherosclerosis	0.00016	0.00355	CcSEcCtD
Glyburide—Myalgia—Ezetimibe—atherosclerosis	0.00016	0.00355	CcSEcCtD
Glyburide—Confusional state—Lovastatin—atherosclerosis	0.000158	0.0035	CcSEcCtD
Glyburide—SLC15A1—liver—atherosclerosis	0.000156	0.0103	CbGeAlD
Glyburide—Vision blurred—Niacin—atherosclerosis	0.000155	0.00344	CcSEcCtD
Glyburide—Confusional state—Ezetimibe—atherosclerosis	0.000155	0.00343	CcSEcCtD
Glyburide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000153	0.0034	CcSEcCtD
Glyburide—Vision blurred—Pravastatin—atherosclerosis	0.000153	0.00339	CcSEcCtD
Glyburide—Myalgia—Simvastatin—atherosclerosis	0.000153	0.00338	CcSEcCtD
Glyburide—Arthralgia—Simvastatin—atherosclerosis	0.000153	0.00338	CcSEcCtD
Glyburide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000152	0.00337	CcSEcCtD
Glyburide—Tremor—Pravastatin—atherosclerosis	0.000152	0.00337	CcSEcCtD
Glyburide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000151	0.00335	CcSEcCtD
Glyburide—Nervous system disorder—Ezetimibe—atherosclerosis	0.00015	0.00334	CcSEcCtD
Glyburide—Angioedema—Niacin—atherosclerosis	0.00015	0.00334	CcSEcCtD
Glyburide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00015	0.00333	CcSEcCtD
Glyburide—Anaemia—Pravastatin—atherosclerosis	0.00015	0.00332	CcSEcCtD
Glyburide—Anorexia—Lovastatin—atherosclerosis	0.000149	0.00331	CcSEcCtD
Glyburide—Angioedema—Pravastatin—atherosclerosis	0.000148	0.00328	CcSEcCtD
Glyburide—Confusional state—Simvastatin—atherosclerosis	0.000148	0.00327	CcSEcCtD
Glyburide—Leukopenia—Niacin—atherosclerosis	0.000147	0.00327	CcSEcCtD
Glyburide—Urticaria—Rosuvastatin—atherosclerosis	0.000147	0.00325	CcSEcCtD
Glyburide—Oedema—Simvastatin—atherosclerosis	0.000146	0.00324	CcSEcCtD
Glyburide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000146	0.00324	CcSEcCtD
Glyburide—Leukopenia—Pravastatin—atherosclerosis	0.000145	0.00322	CcSEcCtD
Glyburide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000143	0.00318	CcSEcCtD
Glyburide—ABCB1—blood vessel—atherosclerosis	0.000143	0.00938	CbGeAlD
Glyburide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000142	0.00316	CcSEcCtD
Glyburide—Paraesthesia—Lovastatin—atherosclerosis	0.00014	0.00311	CcSEcCtD
Glyburide—Arthralgia—Niacin—atherosclerosis	0.00014	0.00311	CcSEcCtD
Glyburide—Myalgia—Niacin—atherosclerosis	0.00014	0.00311	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00014	0.0031	CcSEcCtD
Glyburide—Anorexia—Simvastatin—atherosclerosis	0.000139	0.00309	CcSEcCtD
Glyburide—Dyspnoea—Lovastatin—atherosclerosis	0.000139	0.00309	CcSEcCtD
Glyburide—Myalgia—Pravastatin—atherosclerosis	0.000138	0.00306	CcSEcCtD
Glyburide—Arthralgia—Pravastatin—atherosclerosis	0.000138	0.00306	CcSEcCtD
Glyburide—Paraesthesia—Ezetimibe—atherosclerosis	0.000138	0.00306	CcSEcCtD
Glyburide—Dyspepsia—Lovastatin—atherosclerosis	0.000138	0.00305	CcSEcCtD
Glyburide—ABCC1—adipose tissue—atherosclerosis	0.000137	0.00904	CbGeAlD
Glyburide—ABCC3—liver—atherosclerosis	0.000137	0.00901	CbGeAlD
Glyburide—Dyspnoea—Ezetimibe—atherosclerosis	0.000137	0.00303	CcSEcCtD
Glyburide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000136	0.00302	CcSEcCtD
Glyburide—Decreased appetite—Lovastatin—atherosclerosis	0.000136	0.00302	CcSEcCtD
Glyburide—Dyspepsia—Ezetimibe—atherosclerosis	0.000135	0.00299	CcSEcCtD
Glyburide—Oedema—Niacin—atherosclerosis	0.000134	0.00298	CcSEcCtD
Glyburide—Confusional state—Pravastatin—atherosclerosis	0.000133	0.00296	CcSEcCtD
Glyburide—Decreased appetite—Ezetimibe—atherosclerosis	0.000133	0.00296	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000133	0.00296	CcSEcCtD
Glyburide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000132	0.00294	CcSEcCtD
Glyburide—Asthenia—Rosuvastatin—atherosclerosis	0.000132	0.00294	CcSEcCtD
Glyburide—Oedema—Pravastatin—atherosclerosis	0.000132	0.00293	CcSEcCtD
Glyburide—Shock—Niacin—atherosclerosis	0.000132	0.00293	CcSEcCtD
Glyburide—Paraesthesia—Simvastatin—atherosclerosis	0.000131	0.00291	CcSEcCtD
Glyburide—Pruritus—Rosuvastatin—atherosclerosis	0.000131	0.0029	CcSEcCtD
Glyburide—Dyspnoea—Simvastatin—atherosclerosis	0.00013	0.00289	CcSEcCtD
Glyburide—Hyperhidrosis—Niacin—atherosclerosis	0.00013	0.00288	CcSEcCtD
Glyburide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000129	0.00287	CcSEcCtD
Glyburide—Feeling abnormal—Lovastatin—atherosclerosis	0.000129	0.00286	CcSEcCtD
Glyburide—Dyspepsia—Simvastatin—atherosclerosis	0.000129	0.00286	CcSEcCtD
Glyburide—Anorexia—Niacin—atherosclerosis	0.000128	0.00284	CcSEcCtD
Glyburide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000128	0.00284	CcSEcCtD
Glyburide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000128	0.00284	CcSEcCtD
Glyburide—SLCO2B1—liver—atherosclerosis	0.000128	0.0084	CbGeAlD
Glyburide—Decreased appetite—Simvastatin—atherosclerosis	0.000127	0.00282	CcSEcCtD
Glyburide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000126	0.0028	CcSEcCtD
Glyburide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000126	0.0028	CcSEcCtD
Glyburide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000126	0.0028	CcSEcCtD
Glyburide—Anorexia—Pravastatin—atherosclerosis	0.000126	0.0028	CcSEcCtD
Glyburide—Hypotension—Niacin—atherosclerosis	0.000126	0.00278	CcSEcCtD
Glyburide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000125	0.00278	CcSEcCtD
Glyburide—Urticaria—Lovastatin—atherosclerosis	0.000124	0.00276	CcSEcCtD
Glyburide—Abdominal pain—Lovastatin—atherosclerosis	0.000124	0.00274	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000122	0.00271	CcSEcCtD
Glyburide—Urticaria—Ezetimibe—atherosclerosis	0.000122	0.0027	CcSEcCtD
Glyburide—Abdominal pain—Ezetimibe—atherosclerosis	0.000121	0.00269	CcSEcCtD
Glyburide—Paraesthesia—Niacin—atherosclerosis	0.000121	0.00268	CcSEcCtD
Glyburide—Feeling abnormal—Simvastatin—atherosclerosis	0.000121	0.00267	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00012	0.00267	CcSEcCtD
Glyburide—Dyspnoea—Niacin—atherosclerosis	0.00012	0.00266	CcSEcCtD
Glyburide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00012	0.00265	CcSEcCtD
Glyburide—Paraesthesia—Pravastatin—atherosclerosis	0.000119	0.00263	CcSEcCtD
Glyburide—Dyspepsia—Niacin—atherosclerosis	0.000118	0.00262	CcSEcCtD
Glyburide—Dyspnoea—Pravastatin—atherosclerosis	0.000118	0.00262	CcSEcCtD
Glyburide—CYP2C9—cardiovascular system—atherosclerosis	0.000118	0.00776	CbGeAlD
Glyburide—SLCO1A2—liver—atherosclerosis	0.000117	0.00773	CbGeAlD
Glyburide—Decreased appetite—Niacin—atherosclerosis	0.000117	0.00259	CcSEcCtD
Glyburide—ALB—liver—atherosclerosis	0.000117	0.00768	CbGeAlD
Glyburide—Dyspepsia—Pravastatin—atherosclerosis	0.000116	0.00258	CcSEcCtD
Glyburide—Rash—Rosuvastatin—atherosclerosis	0.000116	0.00258	CcSEcCtD
Glyburide—Dermatitis—Rosuvastatin—atherosclerosis	0.000116	0.00258	CcSEcCtD
Glyburide—Urticaria—Simvastatin—atherosclerosis	0.000116	0.00258	CcSEcCtD
Glyburide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000116	0.00257	CcSEcCtD
Glyburide—Abdominal pain—Simvastatin—atherosclerosis	0.000116	0.00256	CcSEcCtD
Glyburide—Headache—Rosuvastatin—atherosclerosis	0.000116	0.00256	CcSEcCtD
Glyburide—Hypersensitivity—Lovastatin—atherosclerosis	0.000115	0.00256	CcSEcCtD
Glyburide—Decreased appetite—Pravastatin—atherosclerosis	0.000115	0.00255	CcSEcCtD
Glyburide—ABCG2—adipose tissue—atherosclerosis	0.000114	0.00749	CbGeAlD
Glyburide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000113	0.00251	CcSEcCtD
Glyburide—Asthenia—Lovastatin—atherosclerosis	0.000112	0.00249	CcSEcCtD
Glyburide—Pruritus—Lovastatin—atherosclerosis	0.000111	0.00245	CcSEcCtD
Glyburide—Asthenia—Ezetimibe—atherosclerosis	0.00011	0.00244	CcSEcCtD
Glyburide—Gastrointestinal pain—Niacin—atherosclerosis	0.00011	0.00244	CcSEcCtD
Glyburide—Nausea—Rosuvastatin—atherosclerosis	0.00011	0.00243	CcSEcCtD
Glyburide—ABCC2—liver—atherosclerosis	0.000109	0.0072	CbGeAlD
Glyburide—Feeling abnormal—Pravastatin—atherosclerosis	0.000109	0.00242	CcSEcCtD
Glyburide—Pruritus—Ezetimibe—atherosclerosis	0.000109	0.00241	CcSEcCtD
Glyburide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000108	0.0024	CcSEcCtD
Glyburide—Hypersensitivity—Simvastatin—atherosclerosis	0.000108	0.00239	CcSEcCtD
Glyburide—Diarrhoea—Lovastatin—atherosclerosis	0.000107	0.00237	CcSEcCtD
Glyburide—Urticaria—Niacin—atherosclerosis	0.000107	0.00237	CcSEcCtD
Glyburide—Abdominal pain—Niacin—atherosclerosis	0.000106	0.00236	CcSEcCtD
Glyburide—Urticaria—Pravastatin—atherosclerosis	0.000105	0.00233	CcSEcCtD
Glyburide—Asthenia—Simvastatin—atherosclerosis	0.000105	0.00233	CcSEcCtD
Glyburide—Diarrhoea—Ezetimibe—atherosclerosis	0.000105	0.00233	CcSEcCtD
Glyburide—Abdominal pain—Pravastatin—atherosclerosis	0.000105	0.00232	CcSEcCtD
Glyburide—Pruritus—Simvastatin—atherosclerosis	0.000104	0.0023	CcSEcCtD
Glyburide—Diarrhoea—Simvastatin—atherosclerosis	0.0001	0.00222	CcSEcCtD
Glyburide—Vomiting—Lovastatin—atherosclerosis	9.94e-05	0.00221	CcSEcCtD
Glyburide—Hypersensitivity—Niacin—atherosclerosis	9.9e-05	0.00219	CcSEcCtD
Glyburide—Rash—Lovastatin—atherosclerosis	9.86e-05	0.00219	CcSEcCtD
Glyburide—Dermatitis—Lovastatin—atherosclerosis	9.85e-05	0.00219	CcSEcCtD
Glyburide—Headache—Lovastatin—atherosclerosis	9.8e-05	0.00217	CcSEcCtD
Glyburide—Vomiting—Ezetimibe—atherosclerosis	9.75e-05	0.00216	CcSEcCtD
Glyburide—Hypersensitivity—Pravastatin—atherosclerosis	9.74e-05	0.00216	CcSEcCtD
Glyburide—Rash—Ezetimibe—atherosclerosis	9.67e-05	0.00215	CcSEcCtD
Glyburide—Dermatitis—Ezetimibe—atherosclerosis	9.66e-05	0.00214	CcSEcCtD
Glyburide—Asthenia—Niacin—atherosclerosis	9.64e-05	0.00214	CcSEcCtD
Glyburide—ABCC1—liver—atherosclerosis	9.63e-05	0.00634	CbGeAlD
Glyburide—Headache—Ezetimibe—atherosclerosis	9.61e-05	0.00213	CcSEcCtD
Glyburide—Pruritus—Niacin—atherosclerosis	9.5e-05	0.00211	CcSEcCtD
Glyburide—Asthenia—Pravastatin—atherosclerosis	9.49e-05	0.0021	CcSEcCtD
Glyburide—CYP2C19—liver—atherosclerosis	9.4e-05	0.00619	CbGeAlD
Glyburide—Pruritus—Pravastatin—atherosclerosis	9.36e-05	0.00208	CcSEcCtD
Glyburide—Vomiting—Simvastatin—atherosclerosis	9.3e-05	0.00206	CcSEcCtD
Glyburide—Nausea—Lovastatin—atherosclerosis	9.29e-05	0.00206	CcSEcCtD
Glyburide—Rash—Simvastatin—atherosclerosis	9.22e-05	0.00205	CcSEcCtD
Glyburide—Dermatitis—Simvastatin—atherosclerosis	9.22e-05	0.00204	CcSEcCtD
Glyburide—Diarrhoea—Niacin—atherosclerosis	9.19e-05	0.00204	CcSEcCtD
Glyburide—Headache—Simvastatin—atherosclerosis	9.16e-05	0.00203	CcSEcCtD
Glyburide—Nausea—Ezetimibe—atherosclerosis	9.11e-05	0.00202	CcSEcCtD
Glyburide—Diarrhoea—Pravastatin—atherosclerosis	9.05e-05	0.00201	CcSEcCtD
Glyburide—Nausea—Simvastatin—atherosclerosis	8.69e-05	0.00193	CcSEcCtD
Glyburide—Vomiting—Niacin—atherosclerosis	8.54e-05	0.00189	CcSEcCtD
Glyburide—Gliclazide—ALB—atherosclerosis	8.53e-05	0.0542	CrCbGaD
Glyburide—Rash—Niacin—atherosclerosis	8.47e-05	0.00188	CcSEcCtD
Glyburide—Dermatitis—Niacin—atherosclerosis	8.46e-05	0.00188	CcSEcCtD
Glyburide—Headache—Niacin—atherosclerosis	8.42e-05	0.00187	CcSEcCtD
Glyburide—Vomiting—Pravastatin—atherosclerosis	8.41e-05	0.00187	CcSEcCtD
Glyburide—Rash—Pravastatin—atherosclerosis	8.34e-05	0.00185	CcSEcCtD
Glyburide—Dermatitis—Pravastatin—atherosclerosis	8.33e-05	0.00185	CcSEcCtD
Glyburide—Headache—Pravastatin—atherosclerosis	8.29e-05	0.00184	CcSEcCtD
Glyburide—Nausea—Niacin—atherosclerosis	7.98e-05	0.00177	CcSEcCtD
Glyburide—ABCG2—liver—atherosclerosis	7.98e-05	0.00525	CbGeAlD
Glyburide—Nausea—Pravastatin—atherosclerosis	7.86e-05	0.00174	CcSEcCtD
Glyburide—CYP2C9—liver—atherosclerosis	7.29e-05	0.0048	CbGeAlD
Glyburide—ABCB1—cardiovascular system—atherosclerosis	6.36e-05	0.00419	CbGeAlD
Glyburide—ABCB1—adipose tissue—atherosclerosis	5.61e-05	0.00369	CbGeAlD
Glyburide—CYP3A4—liver—atherosclerosis	5.56e-05	0.00366	CbGeAlD
Glyburide—ABCB1—liver—atherosclerosis	3.93e-05	0.00259	CbGeAlD
Glyburide—SLCO1A2—Metabolism—CAV1—atherosclerosis	1.79e-06	2.79e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.79e-06	2.79e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—APOB—atherosclerosis	1.79e-06	2.78e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—APOA1—atherosclerosis	1.79e-06	2.78e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.78e-06	2.77e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—LPA—atherosclerosis	1.78e-06	2.77e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—INS—atherosclerosis	1.78e-06	2.76e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.77e-06	2.75e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.76e-06	2.74e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.76e-06	2.74e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—MTHFR—atherosclerosis	1.75e-06	2.72e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.74e-06	2.71e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTM1—atherosclerosis	1.74e-06	2.71e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.74e-06	2.71e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NAMPT—atherosclerosis	1.74e-06	2.7e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.73e-06	2.69e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—LIPC—atherosclerosis	1.73e-06	2.69e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—BGN—atherosclerosis	1.73e-06	2.68e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOC3—atherosclerosis	1.72e-06	2.67e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARA—atherosclerosis	1.72e-06	2.67e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.71e-06	2.66e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SERPINE1—atherosclerosis	1.71e-06	2.66e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—LPL—atherosclerosis	1.71e-06	2.66e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOA5—atherosclerosis	1.71e-06	2.65e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—LDLR—atherosclerosis	1.71e-06	2.65e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALOX5—atherosclerosis	1.7e-06	2.64e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ALB—atherosclerosis	1.7e-06	2.64e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GPX1—atherosclerosis	1.67e-06	2.59e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CETP—atherosclerosis	1.67e-06	2.59e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AGT—atherosclerosis	1.66e-06	2.58e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—INS—atherosclerosis	1.66e-06	2.58e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.66e-06	2.58e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.64e-06	2.56e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.64e-06	2.54e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NOS3—atherosclerosis	1.63e-06	2.54e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CG—atherosclerosis	1.63e-06	2.54e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—APOE—atherosclerosis	1.63e-06	2.53e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ALB—atherosclerosis	1.63e-06	2.53e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.63e-06	2.53e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CD36—atherosclerosis	1.63e-06	2.52e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—NOS3—atherosclerosis	1.63e-06	2.52e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CAV1—atherosclerosis	1.61e-06	2.51e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.61e-06	2.5e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—APOA1—atherosclerosis	1.61e-06	2.5e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.61e-06	2.5e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.61e-06	2.5e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—SCARB1—atherosclerosis	1.6e-06	2.48e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.59e-06	2.47e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPARG—atherosclerosis	1.58e-06	2.45e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.56e-06	2.43e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—NOS3—atherosclerosis	1.56e-06	2.42e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.55e-06	2.41e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—LIPC—atherosclerosis	1.55e-06	2.41e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.55e-06	2.41e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—INS—atherosclerosis	1.55e-06	2.4e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOC3—atherosclerosis	1.54e-06	2.4e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—MTHFR—atherosclerosis	1.54e-06	2.39e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—LDLR—atherosclerosis	1.53e-06	2.38e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—atherosclerosis	1.53e-06	2.38e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—atherosclerosis	1.53e-06	2.38e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—SERPINE1—atherosclerosis	1.53e-06	2.37e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NAMPT—atherosclerosis	1.53e-06	2.37e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—LIPC—atherosclerosis	1.52e-06	2.35e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARA—atherosclerosis	1.51e-06	2.35e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—HMGCR—atherosclerosis	1.51e-06	2.34e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOC3—atherosclerosis	1.51e-06	2.34e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CETP—atherosclerosis	1.5e-06	2.33e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—LDLR—atherosclerosis	1.5e-06	2.33e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—atherosclerosis	1.49e-06	2.31e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CG—atherosclerosis	1.47e-06	2.28e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.47e-06	2.28e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AGT—atherosclerosis	1.46e-06	2.27e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CETP—atherosclerosis	1.46e-06	2.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—FABP4—atherosclerosis	1.46e-06	2.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LCAT—atherosclerosis	1.46e-06	2.27e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.46e-06	2.26e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NOS3—atherosclerosis	1.46e-06	2.26e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.44e-06	2.23e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.43e-06	2.23e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—APOE—atherosclerosis	1.43e-06	2.23e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOA4—atherosclerosis	1.43e-06	2.22e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—atherosclerosis	1.43e-06	2.21e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.42e-06	2.21e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CAV1—atherosclerosis	1.42e-06	2.21e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARG—atherosclerosis	1.42e-06	2.2e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—atherosclerosis	1.42e-06	2.2e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—APOA1—atherosclerosis	1.42e-06	2.2e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.42e-06	2.2e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—LIPC—atherosclerosis	1.42e-06	2.2e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOC3—atherosclerosis	1.41e-06	2.19e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.41e-06	2.18e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SCARB1—atherosclerosis	1.4e-06	2.18e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—LDLR—atherosclerosis	1.4e-06	2.17e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.4e-06	2.17e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—INS—atherosclerosis	1.39e-06	2.16e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CETP—atherosclerosis	1.37e-06	2.12e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.36e-06	2.11e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—NOS3—atherosclerosis	1.36e-06	2.11e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.35e-06	2.1e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ABCA1—atherosclerosis	1.35e-06	2.09e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—atherosclerosis	1.33e-06	2.07e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HMGCR—atherosclerosis	1.32e-06	2.05e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.31e-06	2.03e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.3e-06	2.02e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.3e-06	2.01e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CG—atherosclerosis	1.29e-06	2.01e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—atherosclerosis	1.28e-06	1.98e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.27e-06	1.98e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARG—atherosclerosis	1.25e-06	1.94e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—atherosclerosis	1.24e-06	1.93e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.24e-06	1.92e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.23e-06	1.91e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.23e-06	1.91e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.23e-06	1.91e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOA2—atherosclerosis	1.23e-06	1.91e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—INS—atherosclerosis	1.23e-06	1.9e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.22e-06	1.9e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—NOS3—atherosclerosis	1.22e-06	1.9e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.22e-06	1.89e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.21e-06	1.88e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ABCA1—atherosclerosis	1.18e-06	1.83e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—atherosclerosis	1.18e-06	1.83e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LPA—atherosclerosis	1.18e-06	1.83e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—HMOX1—atherosclerosis	1.15e-06	1.79e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BGN—atherosclerosis	1.14e-06	1.77e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOA5—atherosclerosis	1.13e-06	1.75e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—atherosclerosis	1.12e-06	1.74e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—atherosclerosis	1.12e-06	1.73e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.11e-06	1.73e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK3—atherosclerosis	1.11e-06	1.73e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOB—atherosclerosis	1.11e-06	1.72e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.1e-06	1.71e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.08e-06	1.69e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—atherosclerosis	1.08e-06	1.68e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—atherosclerosis	1.08e-06	1.67e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NOS3—atherosclerosis	1.07e-06	1.67e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—LPL—atherosclerosis	1.06e-06	1.64e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.05e-06	1.63e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—atherosclerosis	1.04e-06	1.62e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.04e-06	1.61e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GPX1—atherosclerosis	1.03e-06	1.6e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—HMOX1—atherosclerosis	1.01e-06	1.57e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CD36—atherosclerosis	1e-06	1.56e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK3—atherosclerosis	9.94e-07	1.54e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOB—atherosclerosis	9.92e-07	1.54e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—atherosclerosis	9.83e-07	1.53e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOB—atherosclerosis	9.69e-07	1.5e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—atherosclerosis	9.65e-07	1.5e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—atherosclerosis	9.64e-07	1.5e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—MTHFR—atherosclerosis	9.5e-07	1.48e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—LPL—atherosclerosis	9.48e-07	1.47e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—atherosclerosis	9.45e-07	1.47e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—HMOX1—atherosclerosis	9.45e-07	1.47e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—atherosclerosis	9.42e-07	1.46e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NAMPT—atherosclerosis	9.4e-07	1.46e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LIPC—atherosclerosis	9.34e-07	1.45e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARA—atherosclerosis	9.32e-07	1.45e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOC3—atherosclerosis	9.28e-07	1.44e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—LPL—atherosclerosis	9.25e-07	1.44e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GPX1—atherosclerosis	9.25e-07	1.44e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LDLR—atherosclerosis	9.22e-07	1.43e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—atherosclerosis	9.16e-07	1.42e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOB—atherosclerosis	9.05e-07	1.41e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AGT—atherosclerosis	9.03e-07	1.4e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GPX1—atherosclerosis	9.02e-07	1.4e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CETP—atherosclerosis	9.01e-07	1.4e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CD36—atherosclerosis	9e-07	1.4e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOE—atherosclerosis	8.85e-07	1.37e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—atherosclerosis	8.8e-07	1.37e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CD36—atherosclerosis	8.79e-07	1.37e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CAV1—atherosclerosis	8.77e-07	1.36e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOA1—atherosclerosis	8.75e-07	1.36e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—LPL—atherosclerosis	8.64e-07	1.34e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.63e-07	1.34e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MTHFR—atherosclerosis	8.53e-07	1.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GPX1—atherosclerosis	8.43e-07	1.31e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARA—atherosclerosis	8.37e-07	1.3e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTHFR—atherosclerosis	8.33e-07	1.29e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CD36—atherosclerosis	8.21e-07	1.28e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARA—atherosclerosis	8.17e-07	1.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.15e-07	1.27e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AGT—atherosclerosis	8.11e-07	1.26e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—atherosclerosis	7.99e-07	1.24e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOE—atherosclerosis	7.94e-07	1.23e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AGT—atherosclerosis	7.91e-07	1.23e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CAV1—atherosclerosis	7.87e-07	1.22e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOA1—atherosclerosis	7.85e-07	1.22e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTHFR—atherosclerosis	7.78e-07	1.21e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOE—atherosclerosis	7.75e-07	1.2e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARG—atherosclerosis	7.71e-07	1.2e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CAV1—atherosclerosis	7.68e-07	1.19e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOA1—atherosclerosis	7.66e-07	1.19e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARA—atherosclerosis	7.63e-07	1.19e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—INS—atherosclerosis	7.56e-07	1.17e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—atherosclerosis	7.52e-07	1.17e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—atherosclerosis	7.47e-07	1.16e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AGT—atherosclerosis	7.39e-07	1.15e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—atherosclerosis	7.26e-07	1.13e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.26e-07	1.13e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOE—atherosclerosis	7.24e-07	1.13e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CAV1—atherosclerosis	7.18e-07	1.11e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.17e-07	1.11e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—atherosclerosis	7.16e-07	1.11e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOA1—atherosclerosis	7.16e-07	1.11e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—atherosclerosis	7e-07	1.09e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARG—atherosclerosis	6.92e-07	1.07e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—INS—atherosclerosis	6.79e-07	1.05e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARG—atherosclerosis	6.75e-07	1.05e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—atherosclerosis	6.7e-07	1.04e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NOS3—atherosclerosis	6.63e-07	1.03e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—INS—atherosclerosis	6.62e-07	1.03e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.54e-07	1.02e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARG—atherosclerosis	6.31e-07	9.8e-06	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—atherosclerosis	6.24e-07	9.69e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.23e-07	9.68e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—atherosclerosis	6.22e-07	9.66e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—INS—atherosclerosis	6.19e-07	9.61e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—atherosclerosis	6.07e-07	9.43e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—atherosclerosis	6.06e-07	9.42e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOB—atherosclerosis	5.97e-07	9.27e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NOS3—atherosclerosis	5.95e-07	9.24e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NOS3—atherosclerosis	5.81e-07	9.02e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.81e-07	9.02e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LPL—atherosclerosis	5.7e-07	8.85e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—atherosclerosis	5.67e-07	8.81e-06	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—atherosclerosis	5.61e-07	8.72e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPX1—atherosclerosis	5.56e-07	8.64e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.44e-07	8.45e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NOS3—atherosclerosis	5.43e-07	8.43e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CD36—atherosclerosis	5.41e-07	8.41e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—atherosclerosis	5.31e-07	8.25e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.13e-07	7.97e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARA—atherosclerosis	5.03e-07	7.82e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.96e-07	7.71e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—atherosclerosis	4.94e-07	7.67e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AGT—atherosclerosis	4.87e-07	7.57e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOE—atherosclerosis	4.78e-07	7.42e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CAV1—atherosclerosis	4.73e-07	7.35e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOA1—atherosclerosis	4.72e-07	7.33e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.31e-07	6.7e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARG—atherosclerosis	4.16e-07	6.46e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—INS—atherosclerosis	4.08e-07	6.34e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—atherosclerosis	3.74e-07	5.81e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NOS3—atherosclerosis	3.58e-07	5.56e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.27e-07	5.08e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—atherosclerosis	3.05e-07	4.73e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—atherosclerosis	2.74e-07	4.25e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—atherosclerosis	2.67e-07	4.15e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—atherosclerosis	2.49e-07	3.87e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—atherosclerosis	1.64e-07	2.56e-06	CbGpPWpGaD
